RFA-JG-25-137: Innovative Approaches for TB Prevention and Case Finding to END TB
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2024.
Centers for Disease Control and Prevention - ERA offered grants of up to $2.0 million to any type of organization. It expected to make about 2 awards worth $10.0 million in total. Applications closed on March 3, 2025.
From the official notice on Grants.gov, last changed December 30, 2024. Checked November 7, 2026.
- Award ceiling$2.0 million
- Total funding$10.0 million
- Expected awards2
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | November 25, 2024 |
|---|---|
| Deadline | March 3, 2025 |
| Archived by Grants.gov | March 14, 2025 |
Who can apply
This opportunity was open to any type of organization.
All 16 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
N/A
Is this a realistic fit?
- Past Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally awards averaged $1.3 million; this notice allows up to $2.0 million per award.
- No cost sharing or match is required.
What the grant funds
The purpose of this NOFO is to develop, implement, and evaluate evidence-based and innovative approaches under the following two thematic components: Component A - Prevent TB infection and halt progression of TB disease in high-burden settings – with a focus on the following two strategies: TB preventive treatment (TPT) and nutrition; and Component B - Find TB infection and TB disease, including sub-clinical TB, using newer tools and products - in all populations including those at increased/higher risk for TB (i.e., PLHIV, children, displaced persons, healthcare workers, economically disadvantaged persons with other co-morbid conditions [alcohol use disorders, diabetes mellitus, persons who use illicit substances, undernourished], and older adults).
Who has won Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally grants before
From fiscal 2021 to 2025, Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally (93.494) awarded $18.4 million across 14 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Baylor College of Medicine | Texas | 1 | $5.3 million |
| United Nations Office for Project Services | 1 | $4.2 million | |
| Path | Washington | 1 | $2.7 million |
| World Health Organization, Somalia | 1 | $1.3 million | |
| Union Internat Tuberculose Maladie Respi | 1 | $1.3 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-JG-25-137 still open?
No. It closed on March 3, 2025.
Who can apply for Innovative Approaches for TB Prevention and Case Finding to END TB?
Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Innovative Approaches for TB Prevention and Case Finding to END TB?
Closed March 3, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $2.0 million each. About $10.0 million in total across about 2 awards.
Who has won Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally grants before?
The largest recipients over five fiscal years were Baylor College of Medicine, United Nations Office for Project Services, Path. The program made 14 awards worth $18.4 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)